MedTrace Logo

Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis

NCT06602869 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2025-07-10

No results posted yet for this study

Summary

This study evaluates a diagnostic serological test for Non-Tuberculous Mycobacteria (NTM) infection in cystic fibrosis patients by measuring T cell response. It aims to highlight a dynamic response associated to the pathogen's presence. This multicenter case-control study involves two populations, providing a better understanding of the circulating T-IFNγ-MNT response in these patients.

Conditions

  • Non-Tuberculous Mycobacterial Pneumonia

Interventions

OTHER

Scheduled visit (V1)

During the scheduled visit (V1), as part of routine care, a blood draw will be performed. On this occasion, an additional 7 ml tube will be collected to perform serology and culture. This will help define the group (NTM+ Cases/NTM- Controls) and measure cellular biomarkers.

Sponsors & Collaborators

  • Hôpital Cochin

    collaborator OTHER

  • Cystic Fibrosis Foundation

    collaborator OTHER

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Raphael CHIRON, MD · Hôpital Arnaud de Villeneuve

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-17
Primary Completion
2026-08-01
Completion
2026-09-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06602869 on ClinicalTrials.gov